Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...
The dip was slight but was the first such decline in a decade. Separately, a study links Ozempic with an increased risk of a rare form of vision loss, and another study links seed oils with an ...
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
The fundamentals of Novo and Lilly do look robust, but it is always wise to avoid putting all of your eggs in one basket.
It's been six months since I accidentally poisoned myself with a weight-loss jab I shouldn't have taken. But while the memory ...
The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...
Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
10h
The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...
He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...
And it gets even worse Since the above photo was taken, Ice Spice has lost even more weight. Now the weight loss is evident ...
Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication often sold under the brand ...
Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback